Tamara Law

507 total citations
15 papers, 149 citations indexed

About

Tamara Law is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Tamara Law has authored 15 papers receiving a total of 149 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 8 papers in Hematology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Tamara Law's work include Acute Lymphoblastic Leukemia research (12 papers), Acute Myeloid Leukemia Research (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Tamara Law is often cited by papers focused on Acute Lymphoblastic Leukemia research (12 papers), Acute Myeloid Leukemia Research (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Tamara Law collaborates with scholars based in Australia, Germany and Netherlands. Tamara Law's co-authors include Rosemary Sutton, Nicola C. Venn, Michelle Haber, Glenn M. Marshall, Murray D. Norris, Toby N. Trahair, D. R. A. Dissanayake, Frank Alvaro, Tamás Révész and Tatjana Kilo and has published in prestigious journals such as Blood, PLoS ONE and Clinical Chemistry.

In The Last Decade

Tamara Law

14 papers receiving 145 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tamara Law Australia	6	108	83	53	35	24	15	149
Christiane Chen‐Santel Germany	6	102 0.9×	50 0.6×	37 0.7×	73 2.1×	13 0.5×	14	130
Péter Reményi Hungary	9	76 0.7×	144 1.7×	23 0.4×	44 1.3×	34 1.4×	36	217
Ibrahim Ghemlas Saudi Arabia	6	38 0.4×	57 0.7×	26 0.5×	27 0.8×	23 1.0×	29	109
Kyle Beckman United States	4	51 0.5×	66 0.8×	23 0.4×	23 0.7×	45 1.9×	4	107
Guillaume Hypolite France	8	44 0.4×	59 0.7×	18 0.3×	21 0.6×	77 3.2×	10	151
Jean Hugues Dalle France	6	61 0.6×	108 1.3×	15 0.3×	37 1.1×	38 1.6×	9	198
Peifang Xiao China	6	39 0.4×	121 1.5×	20 0.4×	32 0.9×	28 1.2×	41	175
Shawn H. R. Lee Singapore	7	114 1.1×	53 0.6×	74 1.4×	46 1.3×	41 1.7×	9	172
Marie Jarošová Czechia	6	91 0.8×	96 1.2×	16 0.3×	14 0.4×	86 3.6×	13	150
Aurélie Cabannes‐Hamy France	6	58 0.5×	47 0.6×	15 0.3×	54 1.5×	8 0.3×	21	109

Countries citing papers authored by Tamara Law

Since Specialization

Citations

This map shows the geographic impact of Tamara Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Law more than expected).

Fields of papers citing papers by Tamara Law

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Law. The network helps show where Tamara Law may publish in the future.

Co-authorship network of co-authors of Tamara Law

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara Law. A scholar is included among the top collaborators of Tamara Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara Law. Tamara Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hughes, Elizabeth, David M. Ross, Matthew Greenwood, et al.. (2022). Sensitive Measurement of Minimal Residual Disease in Blood by HAT-PCR. Journal of Molecular Diagnostics. 24(6). 632–641. 2 indexed citations

Sutton, Rosemary, Luciano Dalla Pozza, Seong Lin Khaw, et al.. (2021). Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab. Pediatric Blood & Cancer. 68(5). e28922–e28922. 17 indexed citations

Chen, Dan, Rosemary Sutton, Jodie E. Giles, et al.. (2021). Analytical Quality Controls for ddPCR Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia. Clinical Chemistry. 67(10). 1373–1383.

Grigoriadis, George, David Westerman, Michelle McBean, et al.. (2021). Correlation between a 10‐color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B‐acute lymphoblastic leukemia. Cytometry Part B Clinical Cytometry. 102(2). 115–122. 6 indexed citations

Fitter, Stephen, Chung Hoow Kok, Jacqueline E. Noll, et al.. (2021). CKLF and IL1B transcript levels at diagnosis are predictive of relapse in children with pre‐B‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 193(1). 171–175. 4 indexed citations

Scott, Rodney J., Rosemary Sutton, Tamara Law, et al.. (2020). Enrichment of atypical hyperdiploidy and IKZF1 deletions detected by SNP-microarray in high-risk Australian AIEOP-BFM B-cell acute lymphoblastic leukaemia cohort. Cancer Genetics. 242. 8–14. 4 indexed citations

Morley, Alexander A., Elizabeth Hughes, Matthew Greenwood, et al.. (2018). High-Annealing-Temperature PCR (HAT-PCR) Enables Sensitive Quantification of Minimal Residual Disease (MRD) in Blood in Acute Lymphoblastic Leukaemia (ALL). Blood. 132(Supplement 1). 2831–2831. 2 indexed citations

Sutton, Rosemary, Nicola C. Venn, Tamara Law, et al.. (2017). A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B‐cell acute lymphoblastic leukaemia in children. British Journal of Haematology. 180(4). 550–562. 27 indexed citations

Sutton, Rosemary, Tamara Law, Nicola C. Venn, et al.. (2016). Comparison of MRD Levels and Gene Expression Patterns in MLL-R Versus Non-MLL Infant ALL. Blood. 128(22). 1740–1740. 1 indexed citations

10.

Moorman, Anthony V., Julie Irving, Amir Enshaei, et al.. (2015). Composite Index for Risk Prediction in Relapsed Childhood Acute Lymphoblastic Leukaemia. Haematologica. 100. 195–196. 3 indexed citations

11.

Sartor, Mary, Draga Barbaric, Tamara Law, et al.. (2015). Improved Concordance of Minimal Residual Disease Measurements By Quantitative PCR and 10-Color Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia. Blood. 126(23). 2614–2614. 1 indexed citations

12.

Sutton, Rosemary, Peter J. Shaw, Nicola C. Venn, et al.. (2014). Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia. British Journal of Haematology. 168(3). 395–404. 53 indexed citations

13.

Pozza, Luciano Dalla, Nicola C. Venn, Tamara Law, et al.. (2013). Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease. PLoS ONE. 8(10). e76455–e76455. 13 indexed citations

14.

Goodchild, Amber, Tamara Law, Andrew King, et al.. (2009). Primary Leukocyte Screens for Innate Immune Agonists. SLAS DISCOVERY. 14(6). 723–730. 12 indexed citations

15.

Law, Tamara. (1951). TWO CASES OF SPONTANEOUS DETACHMENT OF THE CHORIOID. The Medical Journal of Australia. 1(12). 445–445. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact